DIG
ARMP icon

Dauntless Investment Group’s Armata Pharmaceuticals ARMP Stock Holding History

Dauntless Investment Group’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Buy
203,891
+113,311
+125% +$1.04M 1.04% 18
2026
Q1 		$928K Buy
90,580
+84,449
+1,377% +$711K 0.61% 22
2025
Q4 		$38.5K Buy
+6,131
New +$33.6K 0.03% 55

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Dauntless Investment Group's ARMP Position: Q2 2026 in Review

Dauntless Investment Group increased its Armata Pharmaceuticals (ARMP) stake by 125% in Q2 2026, buying an estimated $1.04M and bringing the position to 203,891 shares worth $1.32M. The position accounts for 1.04% of the portfolio, ranked #18.

Dauntless Investment Group first reported a position in ARMP in Q4 2025 and has held it in 3 quarters since. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Dauntless Investment Group held 203,891 shares of Armata Pharmaceuticals worth $1.32M as of Q2 2026.
  • Dauntless Investment Group bought 113,311 Armata Pharmaceuticals shares in Q2 2026, an estimated $1.04M.
  • Armata Pharmaceuticals made up 1.04% of Dauntless Investment Group's portfolio in Q2 2026, its #18 holding.
  • Dauntless Investment Group first reported a position in Armata Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Dauntless Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.